Scilex Holding Co Announces It Has Received the Drug Distributor Accreditation From The National Association Of Boards Of Pharmacy
Portfolio Pulse from Benzinga Newsdesk
Scilex Holding Company has received the Drug Distributor Accreditation from the National Association of Boards of Pharmacy, meeting all necessary criteria. This accreditation supports Scilex's focus on non-opioid pain management products.
September 12, 2024 | 1:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Scilex Holding Company has been accredited as a drug distributor by the NABP, which could enhance its credibility and market reach in the non-opioid pain management sector.
The accreditation from NABP is a significant regulatory milestone for Scilex, likely to enhance its credibility and facilitate market expansion. This could positively impact its stock price in the short term as it strengthens its position in the non-opioid pain management market.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100